Screener
KURE vs KEMQ
KraneShares MSCI All China Health Care Index ETF vs KraneShares FTSE Emerging Markets Consumer Technology Index ETF
Key differences
- KEMQ costs 0.15% less per year.
- Over the last 3 years, KEMQ has delivered higher annualized returns.
Side-by-side comparison
| KURE | KEMQ | |
|---|---|---|
| Annual cost (TER) | 0.65% | 0.50% |
| Fund size (AUM) | $82M | $39M |
| Since | 2018 | 2017 |
| Dividend yield | 4.14% | 5.39% |
| Asset class | equity | equity |
| Region | emerging markets | emerging markets |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +3.5% | +33.3% |
| CAGR 3Y | -4.9% | +23.5% |
| CAGR 5Y | -14.7% | -2.6% |
| Sharpe 3Y | -0.14 | 0.79 |
| Volatility 1Y | 26.25% | 25.86% |
| Max drawdown | -68.53% | -70.72% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KURE and KEMQ
Explore further